title: Expanding our therapeutic options: Beta blockers for breast cancer?
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Ganz
authors.forename: Steven W
authors.initials: SW
authors.lastname: Cole
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000401:mortality; D048909:Diabetes Complications / Q000188:drug therapy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008495:Medical Oncology / Q000379:methods; D008954:Models, Biological; D009362:Neoplasm Metastasis; D011433:Propranolol / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000096:biosynthesis; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D011960:Receptors, Estrogen; D001262:Atenolol; D011433:Propranolol